Chau, Kai-Yin

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy

Gegg, M. E., Cooper, J. M., Chau, K.-Y., Rojo, M., Schapira, A. H. V., & Taanman, J.-W. (2010) · Human Molecular Genetics

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 910

Mitochondrial and lysosomal biogenesis are activated following PINK 1/parkin‐mediated mitophagy

Ivankovic, D., Chau, K., Schapira, A. H. V., & Gegg, M. E. (2016) · Journal of Neurochemistry

Autophagy in Disease and TherapyParkinson's Disease Mechanisms and Treatments

Cited by 264

Pink1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy

Pryde, K. R., Smith, H. L., Chau, K.-Y., & Schapira, A. H. V. (2016) · Journal of Cell Biology

Autophagy in Disease and TherapyMitochondrial Function and Pathology

Cited by 185

Insulin Resistance Promotes Parkinson’s Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling

Hong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 133

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration

Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., et al. (2005) · Immunology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 125

α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study

Hurley, M. J., Menozzi, E., Koletsi, S., Bates, R., Gegg, M. E., Chau, K.-Y., Blottière, H. M., Macnaughtan, J., & Schapira, A. H. V. (2023) · Brain Communications

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 22